B. Metzler seel. Sohn & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.06M Buy
365,485
+20,699
+6% +$288K 0.05% 218
2025
Q4
$4.84M Buy
344,786
+310,737
+913% +$4.36M 0.04% 222
2025
Q3
$476K Hold
34,049
﹤0.01% 659
2025
Q2
$512K Hold
34,049
﹤0.01% 641
2025
Q1
$449K Hold
34,049
﹤0.01% 636
2024
Q4
$538K Sell
34,049
-91,651
-73% -$1.38M 0.01% 636
2024
Q3
$2M Sell
125,700
-23,530
-16% -$379K 0.02% 388
2024
Q2
$2.27M Hold
149,230
0.02% 350
2024
Q1
$2.19M Sell
149,230
-16,250
-10% -$237K 0.02% 368
2023
Q4
$2.3M Hold
165,480
0.03% 334
2023
Q3
$2.21M Sell
165,480
-149,230
-47% -$2.02M 0.03% 303
2023
Q2
$3.97M Buy
314,710
+149,230
+90% +$1.74M 0.05% 242
2023
Q1
$1.88M Hold
165,480
0.03% 321
2022
Q4
$1.71M Buy
165,480
+21,815
+15% +$235K 0.03% 330
2022
Q3
$1.5M Hold
143,665
0.03% 343
2022
Q2
$1.59M Buy
143,665
+68,505
+91% +$745K 0.03% 348
2022
Q1
$838K Sell
75,160
-17,810
-19% -$202K 0.01% 509
2021
Q4
$1.22M Sell
92,970
-12,290
-12% -$155K 0.02% 408
2021
Q3
$1.37M Buy
+105,260
New +$1.4M 0.02% 378

Other funds holding RDY

B. Metzler seel. Sohn & Co's RDY Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co increased its Dr. Reddy's Laboratories (RDY) stake by 6% in Q1 2026, buying an estimated $288K and bringing the position to 365,485 shares worth $5.06M. The position accounts for 0.05% of the portfolio, ranked #218.

B. Metzler seel. Sohn & Co first reported a position in RDY in Q3 2021 and has held it in 19 quarters since. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 365,485 shares of Dr. Reddy's Laboratories worth $5.06M as of Q1 2026.
  • B. Metzler seel. Sohn & Co bought 20,699 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $288K.
  • Dr. Reddy's Laboratories made up 0.05% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #218 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Dr. Reddy's Laboratories in Q3 2021 and has held it in 19 quarters since.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.